Vimarsana
Biggest News Aggregation in the World

Mark Poznansky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Poznansky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Poznansky Today - Breaking & Trending Today

MSNBCW All In With Chris Hayes April 15, 2020 - Vimarsana News

MSNBCW All In With Chris Hayes April 15, 2020

The failed test kits, the utter inability for weeks to ramp up testing to know where the virus was and how prevalent it was. The fact that they took way too long to begin to recommend social distancing. The fact that the president during this entire period as the virus was spreading would come out and do a series of song and dance routines to pump up the stock market as if that was the goal instead of taking action on the virus. Right. All those errors are what got us to this point. Right now, there are almost 30,000 americans who have lost their lives. Its an incomprehensible toll. New york c...

Canadian Author Publishes Climate Change Novel - Vimarsana News

Canadian Author Publishes Climate Change Novel

Explaining Climate Change In A Way Everyone Can Understand.

Source: prleap.com
Dyadic's C1 Platform Selected by the Vaccine and Immunotherapy Center ("VIC") at Massachusetts General Hospital as Part of VIC's $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases -October 05, 2023 at 08:32 am EDT - Vimarsana News

Dyadic's C1 Platform Selected by the Vaccine and Immunotherapy Center ("VIC") at Massachusetts General Hospital as Part of VIC's $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases -October 05, 2023 at 08:32 am EDT

JUPITER, Fla., Oct. 05, 2023 -- Dyadic International, Inc. , a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein...

Dyadic's C1 Platform Selected by the Vaccine and Immunotherapy Center ("VIC") at Massachusetts ... | Region - Vimarsana News

Dyadic's C1 Platform Selected by the Vaccine and Immunotherapy Center ("VIC") at Massachusetts ... | Region

JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms

Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Data Demonstrating VaxCelerate Vaccine-Induced Protection Against Viral Pathogens - Vimarsana News

Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Data Demonstrating VaxCelerate Vaccine-Induced Protection Against Viral Pathogens

/PRNewswire/ -- Voltron Therapeutics, a Lucius Partners portfolio company, presented new evidence that demonstrates its VaxCelerate Vaccine platform's...